PainReform Ltd. (NASDAQ:PRFX – Get Rating) was the recipient of a significant decrease in short interest in August. As of August 31st, there was short interest totalling 9,200 shares, a decrease of 56.8% from the August 15th total of 21,300 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 22,800 shares, the days-to-cover ratio is currently 0.4 days.
PainReform Price Performance
PRFX stock opened at $0.73 on Friday. PainReform has a fifty-two week low of $0.62 and a fifty-two week high of $3.32. The business’s 50-day moving average is $0.75 and its two-hundred day moving average is $0.94.
Institutional Inflows and Outflows
PainReform Company Profile
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
- Get a free copy of the StockNews.com research report on PainReform (PRFX)
- No One Told These 3 Stocks It’s a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
Receive News & Ratings for PainReform Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PainReform and related companies with MarketBeat.com's FREE daily email newsletter.